We are live on ! Find out more
7IH

72 Investment Holdings Portfolio holdings

AUM $49.6M
1-Year Est. Return 684.72%
This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+684.72%
3 Year Est. Return
+1,518.31%
5 Year Est. Return
+6,127.68%
10 Year Est. Return
AUM
$38.3M
AUM Growth
+$2.74M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LENZ
1
LENZ Therapeutics
LENZ
$179M
$29.8M 77.84%
1,017,751
KRRO icon
2
Korro Bio
KRRO
$145M
$3.46M 9.02%
276,831
PRAX icon
3
Praxis Precision Medicines
PRAX
$8.11B
$2.77M 7.23%
65,933
ANRO icon
4
Alto Neuroscience
ANRO
$1.04B
$1.47M 3.83%
667,778
CRBU icon
5
Caribou Biosciences
CRBU
$146M
$597K 1.56%
474,067
TSBX
6
DELISTED
Turnstone Biologics
TSBX
$197K 0.52%
549,980

Similar funds

72 Investment Holdings's Q2 2025 Portfolio in Review

As of Q2 2025, 72 Investment Holdings held 6 positions worth $38.3M, up 7.7% from $35.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. 72 Investment Holdings opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • 72 Investment Holdings's ten largest holdings make up 100% of its $38.3M portfolio in Q2 2025.
  • 72 Investment Holdings opened 0 new positions and closed 0 in Q2 2025.
  • 72 Investment Holdings's portfolio value rose 7.7% quarter-over-quarter to $38.3M.

Based on 72 Investment Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.